The JNK Signalsome and its Functions
The JNK Signalsome and its Functions
批准号:
7464527
负责人:
JING LIU
金额:
$5.74万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-05-01 至 2008-09-14
关键词:
AffectApoptosisArchitectureBiochemical GeneticsBiological ProcessCell DeathComplexCuesDataDevelopmentDiabetes MellitusEmbryonic DevelopmentEventGoalsHeart HypertrophyHumanImmune responseInflammationJUN geneKnock-outMAPK8 geneMAPK9 geneMalignant NeoplasmsMediatingMitogen-Activated Protein KinasesMolecularN-terminalObesityPathway interactionsPhosphorylationPhosphotransferasesPhysiologicalPlayPreventionProtein DynamicsProtein IsoformsProtein KinaseProteinsPublic HealthPurposeRecruitment ActivityRegulationResearchRoleSAPKScreening procedureSignal PathwaySignal TransductionStagingStimulusStressTNF geneTNF receptor-associated factor 2TRAF2 geneTherapeuticUbiquitinationYeastsZinc Fingerscancer typeextracellularhuman diseasenovelnovel strategiesresponsestress activated protein kinasetumorigenesisyeast two hybrid system
中文摘要
描述(申请人提供):c-jun氨基末端蛋白激酶(JNK;也称为应激激活蛋白激酶,SAPK)在细胞增殖、分化、程序性死亡和转化中发挥核心作用。大量证据表明,JNK在包括炎症、免疫反应、糖尿病、肥胖、心脏肥大和肿瘤发生在内的许多病理生理事件中是一个关键的调节因子。然而,JNK活性受不同的细胞外刺激调控的分子机制仍不完全清楚。在这个提案中,我们将研究不同的细胞外刺激对JNK的激活是否由JNK信号体介导,JNK信号体是一个动态的蛋白质复合体,包括JNK相关的刺激特异性调节器或调节器(SMOR)。使用遗传和生化方法,我们最近发现JNK形成一种蛋白质复合体,其活性可以由刺激特异性调节因子调节。此外,我们发现两种普遍表达的JNK亚型JNK1和JNK2受到不同细胞外刺激的差异调节。因此,我们假设刺激特异的JNK信号体通过环境刺激和/或胚胎发育线索决定JNK的激活。这一建议是新颖的,因为它将确定JNK信号体是JNK激活的动态和功能蛋白质复合体,并确定JNK1和JNK2在不同发育阶段差异调控的分子机制。这项研究将提出一种新的范式,以了解细胞外刺激调节JNK丝裂原活化蛋白激酶亚家族的分子机制,以及以JNK为靶点预防和治疗人类疾病和癌症的原理。与公共健康相关:细胞信号网络由许多重要的信号通路组成,包括应激激活蛋白激酶JNK通路,该通路在许多病理生理事件中发挥核心作用,并与许多人类疾病和某些类型的癌症有关。然而,在不影响人类正常生理功能的情况下,将JNK作为靶点用于治疗是困难的。这项建议研究了刺激特异性调节剂或调节剂通过特定的细胞外刺激控制JNK激活的分子机制,从而提供了一种新的策略,靶向JNK的独特调节器或调节器,而不是JNK本身,以预防和治疗人类疾病和癌症。
英文摘要
DESCRIPTION (provided by applicant): c-Jun N-terminal protein kinase (JNK; also known as stress-activated protein kinase, SAPK) plays a central role in proliferation, differentiation, programmed cell death and transformation. Overwhelming evidence implicates that JNK is a key regulator in many pathophysiological events including inflammation, immune responses, diabetes, obesity, heart hypertrophy, and oncogenesis. However, the molecular mechanism by which JNK activity is regulated by distinct extracellular stimuli is still incompletely understood. In this proposal, we will investigate whether JNK activation by distinct extracellular stimuli is mediated by a JNK signalsome, which is a dynamic protein complex that includes JNK-associated, stimulus-specific modulators or regulators (SMOR). Using both genetic and biochemical approaches, we recently found that JNK forms a protein complex and its activity can be regulated by stimulus-specific regulators. Furthermore, we found that two ubiquitously expressed JNK isoforms, JNK1 and JNK2, are differentially regulated by various extracellular stimuli. Thus, we hypothesize that the stimulus-specific JNK signalsome determines JNK activation by environmental stimuli and/or embryonic development cues. This proposal is novel, as it will identify the JNK signalsome } a dynamic and functional protein complex for JNK activation, and determine the molecular mechanisms by which JNK1 and JNK2 are differentially regulated at different developmental stages. This study will put forward a novel paradigm regarding the molecular mechanism underlying the regulation of the JNK mitogen-activated protein kinase subfamily by extracellular stimuli and the rationale in targeting JNK for prevention and treatment of human diseases and cancer. PUBLIC HEALTH RELEVANCE: The cell signaling network is composed of many important signaling pathways, including the stress activated protein kinase JNK pathway, which plays a central role in many pathophysiological events and has been implicated in numerous human diseases and certain types of cancer. However, it is difficult to target JNK for therapeutic purposes without affecting normal physiological functions in human. This proposal studies the molecular mechanism by which stimulus-specific modulators or regulators control JNK activation by specific extracellular stimuli, thereby providing a novel strategy to target the unique modulators or regulators of JNK, rather than JNK itself, for prevention and treatment of human diseases and cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The transcription factor Miz1-mediated mechanism of lung aging
-
批准号:10198018
-
项目类别:
-
资助金额:$49.03万
-
财政年份:2020
-
负责人:JING LIU
-
依托单位:
The transcription factor Miz1-mediated mechanisms of lung aging
-
批准号:9764468
-
项目类别:
-
资助金额:$4.69万
-
财政年份:2018
-
负责人:JING LIU
-
依托单位:
Regulation of Inflammation and Acute Lung Injury by the Transcription Factor Miz1
-
批准号:8630795
-
项目类别:
-
资助金额:$39.59万
-
财政年份:2014
-
负责人:JING LIU
-
依托单位:
Regulation of Inflammation and Acute Lung Injury by the Transcription Factor Miz1
-
批准号:8787773
-
项目类别:
-
资助金额:$38.51万
-
财政年份:2014
-
负责人:JING LIU
-
依托单位:
The JNK Signalsome and its Functions
-
批准号:8007522
-
项目类别:
-
资助金额:$7.5万
-
财政年份:2010
-
负责人:JING LIU
-
依托单位:
The JNK Signalsome and its Functions
-
批准号:7841897
-
项目类别:
-
资助金额:$28.4万
-
财政年份:2008
-
负责人:JING LIU
-
依托单位:
The JNK Signalsome and its Functions
-
批准号:8037653
-
项目类别:
-
资助金额:$28.12万
-
财政年份:2008
-
负责人:JING LIU
-
依托单位:
The JNK Signalsome and its Functions
-
批准号:8231495
-
项目类别:
-
资助金额:$28.12万
-
财政年份:2008
-
负责人:JING LIU
-
依托单位:
The JNK Signalsome and its Functions
-
批准号:7608711
-
项目类别:
-
资助金额:$28.69万
-
财政年份:2008
-
负责人:JING LIU
-
依托单位:
The JNK Signalsome and its Functions
-
批准号:7714765
-
项目类别:
-
资助金额:$23.09万
-
财政年份:2008
-
负责人:JING LIU
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: